Effectiveness of Immunoglobulin-Replacement Therapy in Patients with Hematological Malignancies and Secondary Immunodeficiency: A Focus on COVID-19 Infections
Artículo
Material complementario disponible
Artículo
DOAJ
IntroductionIncreased risk of infections in patients with hematological malignancies (HM) is a growing concern. Immunoglobulin-replacement therapy (IgRT) is used to reduce infection risk in patients who develop secondary...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario